Loading…

Effects of racecadotril and loperamide on bacterial proliferation and on the central nervous system of the newborn gnotobiotic piglet

Methods The effects of 4 days of oral administration of different doses of two drugs, an enkephalinase inhibitor (the antisecretory agent, racecadotril) and a μ‐receptor agonist (loperamide), on intestinal growth of a bacterial nonpathogenic strain (Escherichia coli E 404) and on the central nervous...

Full description

Saved in:
Bibliographic Details
Published in:Alimentary pharmacology & therapeutics 1999-12, Vol.13 (s6), p.9-14
Main Authors: Duval‐Iflah, Y., Berard, H., Baumer, P., Guillaume, P., Raibaud, P., Joulin, Y., Lecomte, J.M.
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4052-1cf3fdeeb99e1acf95ca46a0ac273cf0d85285dda24c9e7cb9b0838301ac51d3
cites
container_end_page 14
container_issue s6
container_start_page 9
container_title Alimentary pharmacology & therapeutics
container_volume 13
creator Duval‐Iflah, Y.
Berard, H.
Baumer, P.
Guillaume, P.
Raibaud, P.
Joulin, Y.
Lecomte, J.M.
description Methods The effects of 4 days of oral administration of different doses of two drugs, an enkephalinase inhibitor (the antisecretory agent, racecadotril) and a μ‐receptor agonist (loperamide), on intestinal growth of a bacterial nonpathogenic strain (Escherichia coli E 404) and on the central nervous system (CNS) were compared in newborn gnotobiotic piglets. Results The E. coli content of the proximal jejunum (segment S1) and the E. coli ratio of stomach:segment S1 were similar in the racecadotril (20 mg/kg b.d., n = 5) and control groups. In contrast, in the loperamide group (1 mg/kg b.d., n = 4), the E. coli content of segment S1 and the E. coli ratio stomach:S1 were both significantly higher than with racecadotril or control (P = 0.04 and 0.005, respectively, for E. coli content; P = 0.05 and 0.03, respectively, for stomach:S1). There were no clinical signs of neurotoxicity and no deaths with racecadotril given orally at a high dose of 130 mg/kg b.d. (n = 5) – nearly 60 times the paediatric dosage. In contrast, an equivalent high dose of loperamide (5 mg/kg b.d.) resulted in death in three out of four piglets. Conclusions In contrast to loperamide, racecadotril did not induce bacterial overgrowth and did not produce central neurotoxicity.
doi_str_mv 10.1046/j.1365-2036.1999.00001.x-i1
format article
fullrecord <record><control><sourceid>wiley_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_02696176v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>APT2</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4052-1cf3fdeeb99e1acf95ca46a0ac273cf0d85285dda24c9e7cb9b0838301ac51d3</originalsourceid><addsrcrecordid>eNqVkc2KFDEUhYMoTjv6ChJw5aLK_FSlK4iLZhgdoUEXvQ-p5GYmTXWlSDI__QC-t4klg1vv5sI93zmLcxH6QElLSSc-HVvKRd8wwkVLpZQtKUPbp8bTF2jzrL1EG8KEbNhA-QV6k9KxYGJL2Gt0QYnoRMnaoF_XzoHJCQeHozZgtA05-gnr2eIpLBD1yVvAYcajNhmi1xNeYpi8K1L25V7JsvIdYANzjgWYIT6E-4TTOWU41eyqzvA4hjjj2znkMPqQvcGLv50gv0WvnJ4SvPu7L9Hh6_Xh6qbZ__j2_Wq3b0xHetZQ47izAKOUQLVxsje6E5pow7bcOGKHng29tZp1RsLWjHIkAx84KXBPLb9EH9fYOz2pJfqTjmcVtFc3u72qt1qYoFvxQAv7eWVNDClFcM8GSlT9gzqq2rWqXav6B_XnD-pJ-ep-v7qX-_EE9h_vWnwBvqzAo5_g_D_ZavfzwPhvZCya_A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Effects of racecadotril and loperamide on bacterial proliferation and on the central nervous system of the newborn gnotobiotic piglet</title><source>Wiley</source><creator>Duval‐Iflah, Y. ; Berard, H. ; Baumer, P. ; Guillaume, P. ; Raibaud, P. ; Joulin, Y. ; Lecomte, J.M.</creator><creatorcontrib>Duval‐Iflah, Y. ; Berard, H. ; Baumer, P. ; Guillaume, P. ; Raibaud, P. ; Joulin, Y. ; Lecomte, J.M.</creatorcontrib><description>Methods The effects of 4 days of oral administration of different doses of two drugs, an enkephalinase inhibitor (the antisecretory agent, racecadotril) and a μ‐receptor agonist (loperamide), on intestinal growth of a bacterial nonpathogenic strain (Escherichia coli E 404) and on the central nervous system (CNS) were compared in newborn gnotobiotic piglets. Results The E. coli content of the proximal jejunum (segment S1) and the E. coli ratio of stomach:segment S1 were similar in the racecadotril (20 mg/kg b.d., n = 5) and control groups. In contrast, in the loperamide group (1 mg/kg b.d., n = 4), the E. coli content of segment S1 and the E. coli ratio stomach:S1 were both significantly higher than with racecadotril or control (P = 0.04 and 0.005, respectively, for E. coli content; P = 0.05 and 0.03, respectively, for stomach:S1). There were no clinical signs of neurotoxicity and no deaths with racecadotril given orally at a high dose of 130 mg/kg b.d. (n = 5) – nearly 60 times the paediatric dosage. In contrast, an equivalent high dose of loperamide (5 mg/kg b.d.) resulted in death in three out of four piglets. Conclusions In contrast to loperamide, racecadotril did not induce bacterial overgrowth and did not produce central neurotoxicity.</description><identifier>ISSN: 0269-2813</identifier><identifier>EISSN: 1365-2036</identifier><identifier>DOI: 10.1046/j.1365-2036.1999.00001.x-i1</identifier><identifier>PMID: 10646046</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science Ltd</publisher><subject>Animals ; Animals, Newborn ; Antidiarrheals - pharmacology ; Bacteria - drug effects ; Brain - drug effects ; Digestive System - microbiology ; Germ-Free Life ; Life Sciences ; Loperamide - pharmacology ; Loperamide - toxicity ; Neprilysin - antagonists &amp; inhibitors ; Protease Inhibitors - pharmacology ; Swine ; Thiorphan - analogs &amp; derivatives ; Thiorphan - pharmacology ; Thiorphan - toxicity</subject><ispartof>Alimentary pharmacology &amp; therapeutics, 1999-12, Vol.13 (s6), p.9-14</ispartof><rights>Blackwell Science Ltd</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4052-1cf3fdeeb99e1acf95ca46a0ac273cf0d85285dda24c9e7cb9b0838301ac51d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10646046$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.inrae.fr/hal-02696176$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Duval‐Iflah, Y.</creatorcontrib><creatorcontrib>Berard, H.</creatorcontrib><creatorcontrib>Baumer, P.</creatorcontrib><creatorcontrib>Guillaume, P.</creatorcontrib><creatorcontrib>Raibaud, P.</creatorcontrib><creatorcontrib>Joulin, Y.</creatorcontrib><creatorcontrib>Lecomte, J.M.</creatorcontrib><title>Effects of racecadotril and loperamide on bacterial proliferation and on the central nervous system of the newborn gnotobiotic piglet</title><title>Alimentary pharmacology &amp; therapeutics</title><addtitle>Aliment Pharmacol Ther</addtitle><description>Methods The effects of 4 days of oral administration of different doses of two drugs, an enkephalinase inhibitor (the antisecretory agent, racecadotril) and a μ‐receptor agonist (loperamide), on intestinal growth of a bacterial nonpathogenic strain (Escherichia coli E 404) and on the central nervous system (CNS) were compared in newborn gnotobiotic piglets. Results The E. coli content of the proximal jejunum (segment S1) and the E. coli ratio of stomach:segment S1 were similar in the racecadotril (20 mg/kg b.d., n = 5) and control groups. In contrast, in the loperamide group (1 mg/kg b.d., n = 4), the E. coli content of segment S1 and the E. coli ratio stomach:S1 were both significantly higher than with racecadotril or control (P = 0.04 and 0.005, respectively, for E. coli content; P = 0.05 and 0.03, respectively, for stomach:S1). There were no clinical signs of neurotoxicity and no deaths with racecadotril given orally at a high dose of 130 mg/kg b.d. (n = 5) – nearly 60 times the paediatric dosage. In contrast, an equivalent high dose of loperamide (5 mg/kg b.d.) resulted in death in three out of four piglets. Conclusions In contrast to loperamide, racecadotril did not induce bacterial overgrowth and did not produce central neurotoxicity.</description><subject>Animals</subject><subject>Animals, Newborn</subject><subject>Antidiarrheals - pharmacology</subject><subject>Bacteria - drug effects</subject><subject>Brain - drug effects</subject><subject>Digestive System - microbiology</subject><subject>Germ-Free Life</subject><subject>Life Sciences</subject><subject>Loperamide - pharmacology</subject><subject>Loperamide - toxicity</subject><subject>Neprilysin - antagonists &amp; inhibitors</subject><subject>Protease Inhibitors - pharmacology</subject><subject>Swine</subject><subject>Thiorphan - analogs &amp; derivatives</subject><subject>Thiorphan - pharmacology</subject><subject>Thiorphan - toxicity</subject><issn>0269-2813</issn><issn>1365-2036</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNqVkc2KFDEUhYMoTjv6ChJw5aLK_FSlK4iLZhgdoUEXvQ-p5GYmTXWlSDI__QC-t4klg1vv5sI93zmLcxH6QElLSSc-HVvKRd8wwkVLpZQtKUPbp8bTF2jzrL1EG8KEbNhA-QV6k9KxYGJL2Gt0QYnoRMnaoF_XzoHJCQeHozZgtA05-gnr2eIpLBD1yVvAYcajNhmi1xNeYpi8K1L25V7JsvIdYANzjgWYIT6E-4TTOWU41eyqzvA4hjjj2znkMPqQvcGLv50gv0WvnJ4SvPu7L9Hh6_Xh6qbZ__j2_Wq3b0xHetZQ47izAKOUQLVxsje6E5pow7bcOGKHng29tZp1RsLWjHIkAx84KXBPLb9EH9fYOz2pJfqTjmcVtFc3u72qt1qYoFvxQAv7eWVNDClFcM8GSlT9gzqq2rWqXav6B_XnD-pJ-ep-v7qX-_EE9h_vWnwBvqzAo5_g_D_ZavfzwPhvZCya_A</recordid><startdate>199912</startdate><enddate>199912</enddate><creator>Duval‐Iflah, Y.</creator><creator>Berard, H.</creator><creator>Baumer, P.</creator><creator>Guillaume, P.</creator><creator>Raibaud, P.</creator><creator>Joulin, Y.</creator><creator>Lecomte, J.M.</creator><general>Blackwell Science Ltd</general><general>Wiley</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>1XC</scope></search><sort><creationdate>199912</creationdate><title>Effects of racecadotril and loperamide on bacterial proliferation and on the central nervous system of the newborn gnotobiotic piglet</title><author>Duval‐Iflah, Y. ; Berard, H. ; Baumer, P. ; Guillaume, P. ; Raibaud, P. ; Joulin, Y. ; Lecomte, J.M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4052-1cf3fdeeb99e1acf95ca46a0ac273cf0d85285dda24c9e7cb9b0838301ac51d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Animals</topic><topic>Animals, Newborn</topic><topic>Antidiarrheals - pharmacology</topic><topic>Bacteria - drug effects</topic><topic>Brain - drug effects</topic><topic>Digestive System - microbiology</topic><topic>Germ-Free Life</topic><topic>Life Sciences</topic><topic>Loperamide - pharmacology</topic><topic>Loperamide - toxicity</topic><topic>Neprilysin - antagonists &amp; inhibitors</topic><topic>Protease Inhibitors - pharmacology</topic><topic>Swine</topic><topic>Thiorphan - analogs &amp; derivatives</topic><topic>Thiorphan - pharmacology</topic><topic>Thiorphan - toxicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Duval‐Iflah, Y.</creatorcontrib><creatorcontrib>Berard, H.</creatorcontrib><creatorcontrib>Baumer, P.</creatorcontrib><creatorcontrib>Guillaume, P.</creatorcontrib><creatorcontrib>Raibaud, P.</creatorcontrib><creatorcontrib>Joulin, Y.</creatorcontrib><creatorcontrib>Lecomte, J.M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Alimentary pharmacology &amp; therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Duval‐Iflah, Y.</au><au>Berard, H.</au><au>Baumer, P.</au><au>Guillaume, P.</au><au>Raibaud, P.</au><au>Joulin, Y.</au><au>Lecomte, J.M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of racecadotril and loperamide on bacterial proliferation and on the central nervous system of the newborn gnotobiotic piglet</atitle><jtitle>Alimentary pharmacology &amp; therapeutics</jtitle><addtitle>Aliment Pharmacol Ther</addtitle><date>1999-12</date><risdate>1999</risdate><volume>13</volume><issue>s6</issue><spage>9</spage><epage>14</epage><pages>9-14</pages><issn>0269-2813</issn><eissn>1365-2036</eissn><abstract>Methods The effects of 4 days of oral administration of different doses of two drugs, an enkephalinase inhibitor (the antisecretory agent, racecadotril) and a μ‐receptor agonist (loperamide), on intestinal growth of a bacterial nonpathogenic strain (Escherichia coli E 404) and on the central nervous system (CNS) were compared in newborn gnotobiotic piglets. Results The E. coli content of the proximal jejunum (segment S1) and the E. coli ratio of stomach:segment S1 were similar in the racecadotril (20 mg/kg b.d., n = 5) and control groups. In contrast, in the loperamide group (1 mg/kg b.d., n = 4), the E. coli content of segment S1 and the E. coli ratio stomach:S1 were both significantly higher than with racecadotril or control (P = 0.04 and 0.005, respectively, for E. coli content; P = 0.05 and 0.03, respectively, for stomach:S1). There were no clinical signs of neurotoxicity and no deaths with racecadotril given orally at a high dose of 130 mg/kg b.d. (n = 5) – nearly 60 times the paediatric dosage. In contrast, an equivalent high dose of loperamide (5 mg/kg b.d.) resulted in death in three out of four piglets. Conclusions In contrast to loperamide, racecadotril did not induce bacterial overgrowth and did not produce central neurotoxicity.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science Ltd</pub><pmid>10646046</pmid><doi>10.1046/j.1365-2036.1999.00001.x-i1</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0269-2813
ispartof Alimentary pharmacology & therapeutics, 1999-12, Vol.13 (s6), p.9-14
issn 0269-2813
1365-2036
language eng
recordid cdi_hal_primary_oai_HAL_hal_02696176v1
source Wiley
subjects Animals
Animals, Newborn
Antidiarrheals - pharmacology
Bacteria - drug effects
Brain - drug effects
Digestive System - microbiology
Germ-Free Life
Life Sciences
Loperamide - pharmacology
Loperamide - toxicity
Neprilysin - antagonists & inhibitors
Protease Inhibitors - pharmacology
Swine
Thiorphan - analogs & derivatives
Thiorphan - pharmacology
Thiorphan - toxicity
title Effects of racecadotril and loperamide on bacterial proliferation and on the central nervous system of the newborn gnotobiotic piglet
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T22%3A50%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20racecadotril%20and%20loperamide%20on%20bacterial%20proliferation%20and%20on%20the%20central%20nervous%20system%20of%20the%20newborn%20gnotobiotic%20piglet&rft.jtitle=Alimentary%20pharmacology%20&%20therapeutics&rft.au=Duval%E2%80%90Iflah,%20Y.&rft.date=1999-12&rft.volume=13&rft.issue=s6&rft.spage=9&rft.epage=14&rft.pages=9-14&rft.issn=0269-2813&rft.eissn=1365-2036&rft_id=info:doi/10.1046/j.1365-2036.1999.00001.x-i1&rft_dat=%3Cwiley_hal_p%3EAPT2%3C/wiley_hal_p%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4052-1cf3fdeeb99e1acf95ca46a0ac273cf0d85285dda24c9e7cb9b0838301ac51d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/10646046&rfr_iscdi=true